Using digital health tools to improve care for pregnant refugee women with high blood pressure
Official title: Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
Run by Weill Medical College of Cornell University · NCT06647511 · Data updated 2026-11-12
This study is testing if using smartwatches and blood pressure cuffs can help pregnant refugee women with high blood pressure get better care and catch health issues earlier.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 75 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | September 12, 2024 |
| Main results expected | September 2028 |
| Study ends | September 2028 |
| Registry record updated | April 22, 2026 |
| Trial ID | NCT06647511 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women who are refugees, asylum seekers, or asylees, aged 18 or older, and have access to a personal smartphone.
✕Probably not a fit
Patients who are not refugees or asylum seekers, or those who cannot provide informed consent due to vulnerability, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance the detection of gestational hypertension and related health issues in pregnant refugee women through a digital health monitoring system. Participants will receive smartwatches and electronic blood pressure cuffs to track their health data at home, alongside in-person appointments for baseline and follow-up assessments. The study will evaluate the system's performance in diagnosing hypertension with high sensitivity compared to traditional clinical methods, while also monitoring other pregnancy-related risks over a 24-month period.
Why it matters
Potential benefit: If successful, this approach could significantly improve the early detection and management of hypertension in pregnant refugee women, potentially reducing maternal morbidity and mortality.
How similar studies have gone: While the use of digital health technologies in maternal care is gaining traction, this specific application targeting pregnant refugee women with gestational hypertension is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant * Refugee, asylum seeking, or asylee as designated by the U.S. Government * Greater than or equal to 18 years of age * Has a personal smartphone Exclusion Criteria: * Unable to provide informed consent * Determined by the PI to be in an extremely vulnerable position and therefore not suited for research participation * Planned move from the New York City (NYC) area within the next 24 months
Where it's running
-
Weill Cornell Medicine
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Gunisha Kaur, MA, MD — Weill Medical College of Cornell University
- Study coordinator: Gunisha Kaur, MA, MD
- Email: gus2004@med.cornell.edu
- Phone: (212) 746-2461
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
MH-Rx: Check-in on You, Your Medication, and Your Blood Pressure for Pregnant People
This trial tests whether adding virtual social-support and medication management to remote blood pressure monitoring helps pregnant people with chronic or gestational hypertension.
-
Community health worker support to lower blood pressure after pregnancy with high blood pressure
Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.
-
Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders
This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.
-
Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy
This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.
-
Blood markers (sFlt-1/PlGF, sEng, OPG) for diagnosing and monitoring preeclampsia
This study will test whether three blood markers—the sFlt-1/PlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)—can help diagnose and track preeclampsia in pregnant women between 20 and 36 weeks of gestation.
-
Postpartum high blood pressure: trying enalapril after delivery
This study tests whether giving enalapril after delivery can help postpartum women with hypertensive disorders of pregnancy manage blood pressure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.